Podcasts about pharmd

On this episode, we define osteoporosis and describe its clinical presentations, underlying pathophysiology, and common etiologies. We compare and contrast the efficacy, safety profiles, and appropriate use of various antiresorptive and anabolic agents used in osteoporosis management. We also review current guidelines and evidence-based approaches for the prevention and treatment of osteoporosis, including pharmacological and nonpharmacological interventions. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Pharmacy and Therapeutics (P&T) committees historically operated at the individual hospital level but have evolved into enterprise-wide governance programs due to health system expansion, unprecedented clinical and financial complexity of care, and the emergence of high impact and novel therapeutics. To address this, the Vizient Center for Pharmacy Practice Excellence convened an expert panel that concluded health system enterprise P&T committees are uniquely positioned to balance clinical value with financial stewardship and minimize practice variation. They issued best practice considerations representing a dynamic framework designed to evolve alongside emerging therapies, evolving technologies, and the ongoing transformation of health systems. Joining us today are two members of the expert panel. We have Connor Hanrahan, AVP, enterprise pharmacy services, medication outcomes and stewardship with Intermountain Health and Prabashni Reddy, who at the time of the panel was the executive director of medication use and policy at Mass General Brigham.   Guest speakers:  Prabashni Reddy, RPh, PharmD, MMedSc (former) Executive Director of Medication Use and Policy Mass General Brigham Connor Hanrahan, PharmD, MHA, MS, BCPS, CPHQ AVP, Medication Policy, Outcomes, and Stewardship Intermountain Health, Enterprise Pharmacy Services Host: Kerry Schwarz, PharmD, MPH   Senior Clinical Manager, Evidence-Based Medicine and Outcomes  Center for Pharmacy Practice Excellence (CPPE)   Show Notes:  [01:02-03:38] The value Prabashni and Conor saw in joining the expert panel [03:39-05:33] What Prabashni and Conor learned from interactions during the expert panel  [05:34-10:55] Intriguing actionable enterprise P&T program insights panelists brought to the table that listeners can use [10:56-14:01] Use of criteria and principles to create successful and broadly applicable best practices [14:56-16:00] How our listeners can put this panel's best practices into action   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:PrEP candidacy Selection of individualized regimensKey barriers to PrEP useStrategies for overcoming key barriers to PrEP accessEvolving state-based legislation on PrEP provision by pharmacistsModels of pharmacy-managed PrEPStrategies for addressing inequities in PrEP careComprehensive HIV prevention servicesPresenters:Tessa Rife-Pennington, PharmD, BCGPDr. Dawn K. Smith HIV Prevention Clinical FellowAmerican Academy of HIV MedicineVolunteer Assistant Clinical ProfessorUniversity of California, San Francisco, School of PharmacySan Francisco, CaliforniaFrank North, PharmD, MPA, DPLA, DASPLInstructional Assistant Professor, Irma Lerma Rangel College of PharmacyDirector of Learning in PracticeOffice of Interprofessional Practice, Education and ResearchTexas A&M University Health Science CenterPast President, National Pharmaceutical AssociationCollege Station, TexasLink to full program: https://bit.ly/49SLc0yGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTLorin Fisher, PharmD, BCACPClinical Assistant ProfessorUniversity of Iowa College of PharmacyJoshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care.2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns. 0.05 CEU/0.5 HrUAN: 0107-0000-25-330-H01-PInitial release date: 11/10/2025Expiration date: 11/10/2026Additional CPE details can be found here.

Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTLorin Fisher, PharmD, BCACPClinical Assistant ProfessorUniversity of Iowa College of PharmacyJoshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care.2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns. 0.05 CEU/0.5 HrUAN: 0107-0000-25-330-H01-PInitial release date: 11/10/2025Expiration date: 11/10/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

During our conversation, Anthony Morreale, PharmD shares lessons from his remarkable 40-year career in pharmacy, including decades of leadership with the U.S. Department of Veterans Affairs. Dr. Morreale reflects on how curiosity, flexibility, and teamwork helped him identify and fill healthcare gaps, launch clinical pharmacy programs, and mentor future leaders. He discusses the growing importance of informatics, data-driven decision-making, and advanced therapeutics in shaping the future of pharmacy. Now a consultant and expert witness, Dr. Morreale continues to "fix gaps" by applying clinical insight to complex medical-legal cases. His story offers inspiration and practical wisdom for pharmacists at every career stage.   To learn more about Dr. Morreale, visit www.morrealeconsulting.com or connect on LinkedIn: https://www.linkedin.com/in/anthony-morreale-b8753635/    Special thanks to Dr. Pam Schweitzer for nominating Dr. Anthony Morreale as a guest.   Bio (October 2025) - Anthony P. Morreale, PharmD., MBA, BCPS, FASHP, CPEL   Dr. Morreale has demonstrated his professionalism and expertise as a clinician, manager and leader in pharmacy since his pharmacy career began in 1983. He has over 20 years of direct patient care experience as a clinical pharmacist in both acute and ambulatory care. In addition, he has decades of experience as a pharmacy manager, leader and executive. Dr. Morreale is board certified in pharmacotherapy and has been recognized by the American Society of Health System Pharmacists as a Certified Pharmacy Executive Leader. Dr. Morreale has been engaged as a business consultant, quality reviewer for standards of practice, and has served as an expert in medical legal cases. Dr. Morreale has expert knowledge and experience in nearly all areas of pharmacy practice including but not limited to:   •  Regulatory, operational and clinical pharmacy standards of practice for large health systems. •  Drug absorption, metabolism, excretion, outcomes, and adverse effects of both pharmaceuticals and street drugs. •  Application of patient genomics to therapeutic response and toxicities of various medications.   Dr. Morreale retired in October 2024 from his role as Associate Chief Consultant for Clinical Pharmacy Services and Policy for the Department of Veterans Affairs (VA) Pharmacy Benefits Management (PBM) in VA Central Office, where he oversaw national clinical pharmacy services, policy development, pay, recruitment, retention and legislation. He also has significant experience in Health Outcomes Research. Dr. Morreale is a highly experienced speaker both nationally and internationally and is very comfortable delivering understandable and succinct messages to various audiences. Dr. Morreale has authored or co-authored over 90 articles, has served on editorial boards, and as a reviewer on a number of professional journals.  He has been actively involved in leadership roles within many pharmacy organizations both nationally and internationally.   Dr. Morreale is the recipient of numerous awards including- ASHP Best Practice Award, ASHP Literature award for innovation, VA Under-Secretary's Innovation Award, JMCP Quality Reviewer Award for Accuracy, San Diego Society Pharmacist of the Year, California Michelotti Public Health Prize, the AMCP Avey Award, and most recently the APhA Distinguished Federal Pharmacist Award in 2018, and the ASHP Award for Excellence in 2020 and the ASHP Best Practice Award 2024.    Links from this episode Dr. Morreale's Website www.morrealeconsulting.com  Dr. Morreale on LinkedIn https://www.linkedin.com/in/anthony-morreale-b8753635/ U.S. Department of Veterans Affairs https://www.va.gov/ The Pharmacist's Voice Podcast Episode 185 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 229 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 251 featuring RDML Pam Schweitzer The Pharmacist's Voice Podcast Episode 133 featuring Dan Krinsky, RPh   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Audiobook Narration Services https://www.kimnewlove.com/narration  ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting Course https://www.kimnewlove.com/podcasting   ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z If you know someone who would like this episode, please share it with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).   Thank you for listening to episode 355 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Tim & Tim discuss whether to pay off your mortgage early or invest, breaking down math, mindset, and goals for 2025's financial landscape. This episode is brought to you by First Horizon. Episode Summary In this episode of the YFP podcast, co-hosts Tim Ulbrich, PharmD, and Tim Baker, CFP®, RICP®, RLP® revisit the frequently asked question: 'Should I pay off my mortgage early or invest the difference?' They discuss how the changing financial landscape, including rising interest rates, market volatility, and inflation, impacts this decision in 2025. They explore the math, emotional factors, and personal financial goals to provide a balanced approach. What you'll learn in this episode: How to evaluate whether paying off your mortgage early or investing the difference makes more sense in today's higher-rate environment. Why the math (interest rates, investment returns, tax impact) and the emotion (stress, freedom, flexibility) both matter when making this decision. How shifts in interest rates, inflation, and cash flow pressures since 2018 change the calculus for pharmacists in 2025. The role of discipline and behavior—why "investing the difference" only works if you actually do it. How a financial planner helps balance data and emotion to build a plan that aligns with your goals, values, and risk tolerance. Mentioned on the Show Your Financial Pharmacist Book a Free Discovery Call with YFP YFP Episode 49 "Should I Pay Off My House Early of Invest?" YFP Episode 68 "Pros/Cons of the Dave Ramsey 7 Baby Steps" YFP Episode 427: "Passive vs Active Investing: Is the Debate Over" YFP Episode 274: "Risk Tolerance vs Risk Capacity (Retirement Planning)"  

On this episode of MaternalRx on the Pharmacy Podcast Network, host Dr. Danielle Raiman Plummer, PharmD, consulting pharmacist, sits down with Mary Kucek, PMP, and Dr. Devin Bustin, MD, co-founders of OvaryIt, creators of the PRISM EHR platform and the OvaryIt Foundation for survivors of domestic abuse and human trafficking. Mary shares her powerful and life-threatening experience with a telemedicine platform that failed to follow contraceptive safety guidelines, an event that changed the course of her career and mission. Together, Mary and Dr. Bustin explain how their NIH-funded research led to the creation of OvaryIt and PRISM: an innovative, pharmacist-centered platform that bridges the safety of in-person care with the accessibility of telehealth. Tune in to hear how retail pharmacists can now lead the next evolution in family planning access, overcoming the barriers to scaling these services, and how technology and policy can empower safer, more equitable reproductive care for all. “Prism will help retail pharmacies become public health access points for central health services.” 

Before every breakthrough in oncology, there's phase I research — where innovation, teamwork, and patient trust come together.In this episode, Dr. R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO, Vice President of Clinical Research and Executive Director of the Emory Clinical Research Office, joins hosts Ginger Blackmon, PharmD, and Maddy Floysand, PharmD, for an inside look at how early-phase clinical trials lay the groundwork for new cancer therapies.Dr. Harvey, also Professor of Hematology/Medical Oncology and Pharmacology and Associate Dean for Clinical Research at Emory University, shares how phase I studies are evolving to balance discovery, safety, and patient care while expanding access beyond academic centers.He talks about:How early-phase trials shape the future of oncology treatmentsCollaboration between academic and community sites to improve access and equityThe vital role of pharmacists in study design, safety, and educationHow AI and data are changing trial design and patient matchingAdvice for clinicians and students interested in research careersDr. Harvey also reflects on the teamwork that drives meaningful progress and what continues to inspire him after decades of leading research that connects science to patient impact.

In this episode, Coach Vinny and Dr. Eryn sit down with Dr. Ashley Dwyer, PharmD, a former pharmacist turned coach who's holistic without the nonsense. She blends holistic coaching, western medicine, anecdotal data, and clinical data to help women optimize their health without falling for the pseudoscience, overtesting, or fear tactics that dominate the functional coaching space. They dive into: Why she left pharmacy to help women through education, not endless prescriptions How she applies evidence-based strategies to her coaching The red flags that separate real health coaching from functional fluff Her personal journey from NPC competitor to a balanced, sustainable approach to fitness and life If you're tired of influencers selling “detoxes” and hormone “fixes,” this conversation will restore your faith in what real coaching looks like. Coach Vinny Email: vinny@balancedbodies.io Instagram: vinnyrusso_balancedbodies Facebook: Vinny Russo Dr. Eryn Email: dr.eryn@balancedbodies.io Instagram: dr.eryn_balancedbodies Facebook: Eryn Stansfield LEGION 20% OFF CODE Go to https://legionathletics.com/ and use the code RUSSO for 20% off your order! About our Guest:Dr. Ashley Dwyer is a licensed Pharmacist, ACE Certified Health Coach, and former NPC athlete who, after going through a slew of her own health issues due to extreme lifestyle habits, left the traditional western medical model to start her own company and really help others through holistic healing. Her team, TeamBDN coaching, specializes in holistic nutrition, macro tracking, hormone optimization, individualized fitness plans, accountability, and community, helping women eat more and reach their health goals. Dr. Ashley is also certified in plant-based nutrition, Health Mindset Coaching, Prenatal & Postpartum Coaching, and Functional Nutrition and Metabolic Science. Her goal is to help as many women as she can feel their best and reverse years of metabolic adaptation + hormone disruption! Website: www.teambdncoaching.com Instgram: @dr.dwyer

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, joined Over the Counter to discuss pharmacists' roles in improving diabetes outcomes as well as reaching patients in their communities.

On this episode, we discuss ulcerative colitis (UC) and describe its clinical presentations, underlying pathophysiology, and common etiologies. We evaluate current clinical guidelines and evidence-based strategies for managing UC. We also compare and contrast the efficacy, safety profiles, and appropriate use of available UC therapies, such as aminosalicylates, corticosteroids, immunomodulators, and biologics.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

In this empowering episode, Teresa sits down with Sara Paxton, a pharmacist turned Certified Health Coach and founder of Nourish Health Coaching. Sara shares her powerful journey from the world of pharmaceuticals—where she once helped cover up symptoms—to discovering the beauty of how our bodies communicate through them. Sara believes that our symptoms are blessings—our body's way of signaling that something needs attention—and that our hormones and cycles tell a story of incredible design. Together, Teresa and Sara dive deep into how gut health impacts hormone balance and metabolism, why the food industry makes healthy living so confusing, and how blood sugar monitoring can transform energy and mood for women. Rooted in her faith and inspired by Romans 12:2 and John 10:10, Sara's mission is clear: to help women feel good in their bodies, restore vitality, and live abundantly as God intended. As a wife, mother of five energetic boys, and passionate health advocate, she reminds us that when women feel better—they do better in every part of life. Key Takeaways: How gut health shapes hormone and metabolic balance Why symptoms are not enemies but messages How to use blood sugar monitoring as a tool for vitality The truth behind the food industry's “healthy” messaging Finding freedom in health to fulfill your God-given purpose Guest: Sara Paxton, PharmD, Certified Health Coach Connect with Sara: www.sarapaxtonnourish.com/home | IG: @sarapaxtonnourish We're thrilled to partner with We Heart Nutrition—a company that's as passionate about women's wellness as we are. From high-quality supplements to trusted nutritional support, We Heart Nutrition helps women feel strong, energized, and nourished from the inside out.

Fluoropyrimidines such as 5-fluorouracil (5-FU) and capecitabine remain cornerstone chemotherapies in oncology. However, for patients with certain DPYD gene variants, these commonly used drugs can cause life-threatening toxicities due to impaired metabolism of the active compounds. In this episode of the Precision Medicine Pharmacist Podcast, host Melissa Smith, PharmD, explores how DPYD genotyping is transforming oncology care by helping clinicians identify patients at risk before toxicity occurs. Joined by Karen Merritt, an advocate for universal DPD testing and leader with the Test4DPD initiative, the discussion sheds light on how pharmacogenomics is shaping safer, more personalized cancer treatment. Together, they explore current evidence, new FDA updates, and implementation frameworks that empower pharmacists and oncology teams to prevent preventable harm through precision medicine.

Joing Robert and Wendy Pilot: Heather Maracle Fahey, PharmD, BCACP Tribal Affiliation: Mohawks of the Bay of Quinte, Rebekah Fineday and Amber Lightfeather with Native Women in Healthcare Consortium

ASHP's Education Director, Hannah Post, is joined by Kristin Zimmerman, Associate Professor at Virginia Commonwealth University Health, to discuss an upcoming Midyear session presented by Marina Trefethen, PharmD, BCPP, Mental Health Clinical Pharmacist Practitioner at the White River Junction Department of Veterans Affairs Healthcare System. The session explores GLP-1 receptor agonist effects on substance use and addictive behaviors in both clinical trials and real-world populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Cardiovascular-kidney-metabolic (CKM) syndrome is progressive, but can be halted or even reversed with effective management. Guests Chiai Ndumele, MD, PhD, and Joe Saseen, PharmD, BCPS, BCACP, describe the role of inflammation and how the biologic factors for diagnosis and treatment are nested within a patient's social context.2023 AHA Statement Cardiovascular-Kidney-Metabolic Health: https://www.ahajournals.org/doi/10.1161/cir.0000000000001184 Related Resources:PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ AHA Cardiovascular Kidney Metabolic Health Presidential Advisory: https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisoryAHA CKM Syndrome Implementation Guide: https://www.heart.org/en/professional/cardiovascular-kidney-metabolic-health/implementationPCNA CKM Resource list: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The bidiretional relationship between cardiac and renal systems means that any dysfunction can cause a cascade of health issues. Learn about team-based care strategies for nurses and other professionals to monitor and manage patients with these conditions from guests Andrew Bzowyckyj, PharmD, BCPS, CDCES, FAPhA, FADCES, and Serina Gbaba, DNP, MBA, FNP-BC.PCNA CKM tools and resources: https://pcna.net/resources/patient-education/patient-information/cardiovascular-kidney-metabolic-syndrome-resources/ IPEC core competencies (Interprofessional Education Collaborative): https://www.ipecollaborative.org/ipec-core-competencies CVD in CKD: Pathophysiological Insights and Therapeutic Options: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050686Social Determinants of CVD:https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319811See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Stephanie Redmond, PharmD, PhD, and founder of Dr. Stephanie's, to explore how pharmacology is transforming the world of supplements and functional medicine. With dual expertise in endocrinology and pharmacotherapy, Dr. Redmond offers a rare perspective on how medications, nutrients, and hormones intersect — and how precision-based formulation is reshaping metabolic health.After years in clinical practice, Dr. Redmond noticed a glaring gap: most supplements on the market are underdosed, underperforming, and poorly understood. Her approach flips the script — using clinically validated, therapeutic dosesof ingredients designed for real efficacy and safety. “It's not about marketing,” she explains. “It's about measurable results.”The conversation dives deep into her breakthrough innovations, including Purify Colostrum, developed using AI-assisted filtration to isolate bioactive glycoproteins compatible with the human body — delivering seven times more anti-inflammatory power than standard colostrum. She also shares insights on her GLP-1 support formulations, designed to complement popular medications like Ozempic by addressing nutrient depletion, digestion, and hormonal balance.Together, Dr. Ekta and Dr. Redmond unpack what ethical, evidence-based supplementation truly looks like — where pharmacology meets function, and science replaces hype.Tune in to hear how Dr. Stephanie Redmond is redefining modern supplementation and why, in today's world, foundational nutrition is no longer optional — it's essential.Learn more about Dr. Stephanie's on their website and social media!CHAPTERS:0:02 – Introduction & Guest Welcome1:01 – Dr. Redmond's Path from Pharmacy to Endocrinology2:18 – Bridging Medicine, Supplements & Pharmacology4:43 – The Role of Pharmacists in Holistic Care7:09 – The Gap in Supplement Education & Dosing8:58 – Colostrum: Nature's “First Milk” Explained11:05 – Human vs. Bovine Colostrum & Compatibility14:44 – Postpartum, Perimenopause & Hormonal Health19:01 – GLP-1 Support Supplements & Metabolic Health27:27 – The Future of Foundational Wellness & Supplement TestingPlease fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf! Hosted on Acast. See acast.com/privacy for more information.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose.  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.

Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical for pharmacy professionals to stay up to date on prevention and treatment options. This episode covers the latest FDA-approved RSV therapies, including vaccines and monoclonal antibodies, while highlighting clinical pearls for use across care settings. Tune in to stay informed and better support patients during the upcoming respiratory season. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKalen Manasco, PharmD, BCPS, BCPPS, FCCP, FPPAProfessorUniversity of Florida College of PharmacyJoshua Davis Kinsey and Kalen Manasco have no relevant financial relationships with ineligible companies to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Differentiate between RSV vaccines and monoclonal antibody therapies, including their indications and target patient populations.2. Identify key counseling points and administration considerations associated with currently available RSV vaccines and monoclonal antibody therapies.0.05 CEU/0.5 HrUAN: 0107-0000-25-312-H01-PInitial release date: 11/3/2025Expiration date: 11/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

As interest grows in the therapeutic potential of ketogenic diets for bipolar disorder, careful attention must be given to drug-diet interactions. Overlapping mechanisms between therapeutic ketosis and mood-stabilizing agents may offer opportunities for synergistic effects, but may also introduce risks related to altered pharmacokinetics, pharmacodynamics, and additive toxicities. In this podcast, Dina N. Ali, MD, and Jonathan Leung, PharmD, discuss the complex picture of trying to optimize treatment outcomes while many research questions are yet to be answered. Ali and Leung are authors of the commentary, "Diet Drug Interactions: Achieving and Maintaining Ketosis As Adjunct to Psychotropic Polypharmacotherapy," which is published in the November-December 2025 issue of the Journal of Clinical Psychopharmacology. The other contributing authors are Mark A. Frye, MD; Iain H. Campbell, PhD; Matej Markota, MD; Mikaela M. Hofer, PharmD, and Heather Standorf, PharmD. doi: 10.1097/JCP.0000000000002074

Listen in as our expert panel explores the clinical challenges of veterinary pharmacology, discussing medications, supplements, and inactive ingredients that can be dangerous to pets. You'll hear practical dispensing and safety guidance, along with evidence-based strategies to help pharmacists protect animal patients from accidental exposure to human medications.Special guests:Alexandria Gochenauer, PharmD, DICVP, FSVHP, FACAStaff Pharmacist and Interim Pharmacy Manager, WalmartPresident-elect of the American College of Veterinary PharmacistsErica Wassack, PharmD, DICVP, FSVHP, FACVPAssociate Pharmacy OfficerPlumb's Veterinary Drugs, Instinct ScienceTina Wismer, DVM, MS, DABVT, DABT Senior DirectorASPCA Poison ControlNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in September 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Med Considerations for Cats and DogsArticle: Don't Chase Your Tail With Pet RxsPodcast: Clinical Capsules - Avoiding Medication Mishaps with Pet PrescriptionsUse code mt1025 at checkout for 10% off a new or upgraded subscription.Send us a text*****

Tim & Tim unpack passive vs. active investing, fees, behavior, and why YFP takes an "actively passive" approach to help pharmacists reach goals. Episode Summary In this episode of the YFP podcast, co-hosts Tim Ulbrich, PharmD and Tim Baker, CFP®, RICP®, RLP® dive into the ongoing debate of passive versus active investing. They break down the definitions of each strategy, discuss where each might fit into a pharmacist's financial plan, and analyze the impact of fees and behavioral factors. Drawing insights from Charles Ellis's The Index Revolution and Dr. Daniel Crosby's The Behavioral Investor, they explore YFP's own investment philosophy and the benefits of an actively passive approach. The episode covers the importance of long-term planning, the impact of fees on investment returns, and why human behavior often works against successful investing. Tune in to see why YFP advocates for a passive approach while actively managing portfolios to align with clients' financial goals. What you'll learn in this episode: The key differences between passive and active investing—and where each approach fits within a pharmacist's financial plan. How investment fees and human behavior can significantly impact long-term returns. Why YFP believes in an "actively passive" investment philosophy that balances discipline with adaptability. Practical takeaways from The Index Revolution and The Behavioral Investor to help you become a more confident, informed investor. Mentioned on the Show Your Financial Pharmacist Your Financial Pharmacist on YouTube The Index Revolution by Charles Ellis Vanguard Research Brief (2020): Putting a value on your value: Quantifying Vanguard Adviser's Alpha The Behavioral Investor by Dr. Daniel Crosby YFP Episode 124: The Behavioral Investor with Dr. Daniel Crosby

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A new MP3 sermon from Christ Academy is now available on SermonAudio with the following details: Title: A New Commandment: Love Like Jesus Subtitle: Explainer Speaker: Peter Jensen PhD, PharmD, DedMin Broadcaster: Christ Academy Event: Devotional Date: 10/30/2025 Bible: Leviticus 19:18; John 13:34-35 Length: 7 min.

Dr. Robert Beltran isn't just a doctor—he's a man who healed himself to heal others.A highly respected triple board-certified surgeon and pharmacist ($MD, PharmD, FACS$),  Dr. Beltran had a decades-long career as an ENT and cosmetic surgeon, giving him a rare, deep understanding of the human body, from biochemistry to the operating room.His life and career changed in 2014 when a severe accident left him battling chronic pain, cognitive fog, and depression.  What traditional medicine couldn't fix, a colleague's suggestion of herbal treatments miraculously did—sparking a rapid turnaround that helped him safely overcome his dependency on prescription pain medication, including oxycodone.This life-altering personal recovery ignited a new mission. Dr. Beltran dedicated the next decade to merging his clinical and scientific background with the power of nature.  Today, as CEO and Chief Formulator of recomnd Nutrition, he applies his surgical precision and pharmacy knowledge to create science-backed, plant-based solutions for physical and cognitive vitality.Join us to hear this inspiring story of resilience and reinvention. Dr. Beltran will share how he challenges conventional thinking on recovery, helping people reclaim their well-being without relying on harsh side effects or stimulants. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Alyssa Mack, PharmD, joined Over the Counter during American Pharmacists Month to discuss how her pharmacy practice has put a focus on increasing clinical services.

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

Are parasites affecting your health without you even realizing it? Parasites can silently affect nutrient absorption, immune balance, and overall health. In this episode, Bryana Gregory, Pharmacist and Physician Liaison with Physicians Preference Pharmacy, explains how parasitic infections can strip the body of essential nutrients and contribute to inflammation, fatigue, autoimmune issues, and other chronic health conditions. Bryana dives deep into two of the most effective antiparasitic compounds of Ivermectin and Mebendazole, and how they work to target different stages of parasitic life cycles. Learn how compounded formulations at Physicians Preference Pharmacy allow for more precise dosing, fewer inactive ingredients, and tailored delivery forms that meet individual needs. She also discusses why over-the-counter Ivermectin legislation raises concerns, emphasizing the importance of professional supervision to ensure proper dosing, safety, and effectiveness.   Discover how compounding makes medications cleaner and more effective, and why it's critical to partner with a knowledgeable pharmacist for personalized care and optimal results. Contact Physicians Preference Pharmacy at 281-828-9088 for personalized compounding options.   Watch now and subscribe to our podcasts at www.HotzePodcast.com.   To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!  

On this episode, we define open-angle glaucoma and describe its clinical presentations, risk factors, and underlying pathophysiolog. We evaluate current guidelines and evidence-based treatment strategies for managing open-angle glaucoma, including pharmacological and procedural interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of topical therapies and alternative options in treating open-angle glaucoma. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Artificial intelligence, or, AI is on everyone's minds, and we're all still figuring out how to trust it, teach it, and use it responsibly. Today we take a deep dive into how AI is affecting the education of current and future pharmacy students. With us is Jennifer Trujillo, associate Dean for education and professor in the Department of Clinical Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences on the University of Colorado Anschutz Medical Campus in Aurora, Colorado, and Logan Tinsen, the clinical pharmacy manager and residency program director at Benefis Hospital in Great Falls, Montana.   Guest speakers:  Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM Associate Dean for Education Professor, Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Logan Tinsen, PharmD, FMPA Clinical Pharmacy Manager and Residency Program Director Benefits Hospitals   Host:   Kerry Schwarz, PharmD, MPH   Senior Clinical Manager, Evidence-Based Medicine and Outcomes  Center for Pharmacy Practice Excellence (CPPE)   Show Notes:  [01:02-03:45] Challenges with AI in pharmacy education [03:46-05:59] The AI adoption spectrum: Pitfalls of extremes between full and limited adoption [06:00-11:18] Approaches to pharmacy education in the early stages of AI [11:19-14:55] Guardrails and safeguards [14:56-16:29] Key takeaways about AI right now for pharmacy educators   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

Send us a textGlutathione is the body's master antioxidant: central to detoxification, oxidative stress control, and cellular repair. Dr. Kevin White sits down with Dr. Nayan Patel, PharmD, adjunct professor at USC and author of The Glutathione Revolution, to unpack what glutathione is, why levels drop with age, and how smart habits and targeted support can move the needle on longevity and performance.“Think of glutathione as the maid of the body: it takes out the trash so your cells can finally get back to living.”                - Dr. Nayan PatelYou'll hear:What glutathione actually does inside your cellsHow alcohol, pollution, and poor sleep drain your reservesWhy oxidative stress accelerates agingHow topical delivery can raise red-blood-cell levels and what to measure while you're improvingLearn more about Dr. Patel's work and his book The Glutathione Revolution at aurowellness.com.

ASHP's education director, Hannah Post, is joined by Curtis Geier, emergency medicine clinical pharmacist at San Francisco General Hospital, as he discusses his upcoming Midyear sessions that focus on the role of pharmacists in the care of patients in cardiac arrest.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Every high-performing business has one thing in common: reliability. Hospitals cannot afford mistakes. Neither can you. In this episode of Beyond The Claim, Vince Perri sits with Anay Moscu, PharmD, BCPS, BCOP, ACRP-CP, Director of Pharmacy for Outpatient Infusion Centers at Moffitt Cancer Center, to uncover the systems that literally save lives and show how you can use them to scale your company faster. What you will learn: • The Stop Error Stack: how hospitals eliminate million-dollar mistakes • Why every business needs independent checks and hard stops • The Empathy with Accountability formula for leading under pressure • How to design checklists people actually follow • AI tools hospitals use today that you can apply to your business Chapters: 00:00 Intro: Checklists That Save Lives 01:52 What Oncology Pharmacy Really Does 05:40 How Clinical Trials and Infusion Workflows Operate 09:28 The Stop Error Stack: Eliminating Mistakes 13:35 Clean Rooms, Barcoding, and Validation 17:10 Building Systems That People Actually Follow 21:22 Hiring For Detail And Team Fit 26:45 Balancing Empathy With Accountability 32:12 Getting Buy-In Across Teams 37:44 AI And Automation In Modern Pharmacy 42:55 Translating Hospital Systems To Business Growth 48:05 Life Advice: Be Present And Give Yourself Grace 52:00 Outro And Free Checklist Guest Contact Links

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.  Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

On Episode 88 of Astonishing Healthcare, we're celebrating Women Pharmacist Day (#WPD2025) and sharing stories from four of our amazing team members: Allison Gallant, PharmD (Sr. Strategic Account Executive), Cindy Strassner, RPh (Customer Success Pharmacist), Lorece Shaw, PharmD (Sr. Director of Prior Authorization and Clinical Care), and Hope Nakazato, PharmD (VP of National Business Development). These women aren't just talking about improving healthcare or celebrating one day - they're actively promoting and implementing change, mentoring the next generation of pharmacists, and building systems to improve clinical workflows and member care.Lorece, Allison, Hope, and Cindy highlight their career journeys, insights on leadership, and the importance of mentorship to their personal and professional development throughout the discussion. They offer unfiltered advice on career growth, overcoming obstacles, staying resilient and expressing confidence in yourself, and how to work together to fix what's broken in pharmacy and health benefits. Whether you're interested in "non-traditional" career paths for pharmacists, curious about how pharmacists work in managed care, or just need some motivation to go for the next big opportunity and a reminder that you've got to be prepared and show up with confidence, per Allison and Lorece, respectively, this episode is for you!Related ContentSigns it is time to change your PBM vendor, and how to overcome common hesitations (by Hope Nakazato, PharmD, MBA)AH018 - What's the Right Path? Post-grad Options for PharmacistsPharmacy Benefits 101: Prior AuthorizationsHealth Benefits 101: The Importance of Clinical ProgramsAH040 - Celebrating Women Pharmacist Day 2024For more content and information about this episode, including the show notes and transcript, please visit Judi Health - Insights.

The 2025 Pharmacist Authors Series concludes today with my interview with Dr. Sandra O. Onye. She wrote Winning Is in My DNA: 15 Minutes of Self-Reflection (a guided journal). If you have not journaled before, there are examples in the book to get you started in the right direction. If you know someone who is interested in journaling, please share this episode with them.   The Pharmacist Authors Series introduces you to pharmacist authors and their books. The goal of the series is to inspire you to write a book too. Links to the other episodes in this series (2023, 2024, and 2025) are below.   The FULL show notes are on thepharmacistsvoice.com. Click the podcast tab, and find episode 353.   Sandra O. Onye is a pharmacist, author, and military healthcare leader who believes in the power of healing — both inside and out. Serving as a pharmacist in the United States Army, Sandra combines clinical excellence with compassion, helping to advance the health and readiness of those who serve. With a Doctor of Pharmacy from Duquesne University and a background in psychology from the University of Pittsburgh, she has spent over a decade blending science, service, and soul to transform how people view health and personal growth. Her journey began behind the pharmacy counter, where she discovered that true care goes beyond prescriptions — it's about empowering people to take charge of their well-being. That passion fuels her mission to highlight the vital role pharmacists play in shaping healthier communities and promoting holistic care. Sandra is also the author of “Winning Is in My DNA: 15 Minutes of Self-Reflection,” a guided journal designed to empower readers to slow down, look inward, and celebrate their achievements. Through her work, she continues to inspire others to live intentionally, lead with compassion, and recognize that every day is a chance to win — from the inside out.   Links from this episode  Winning Is in My DNA: 15 Minutes of Self-Reflection (Amazon link) https://amzn.to/48KTtn3  LinkedIn profile for Sandra O. Onye, PharmD https://www.linkedin.com/in/sandra-onye-75b256290/    2025 Pharmacist Authors Series Part 1 of 3 (June) Episode 336 with Jerry Levin, PhD, LMT - Affirm Yourself: 15 Principles to Retrain the Voice in Your Head. Part 2 of 3 (July) Episode 340 with Ashley Walker, PharmD - Expanding Your Brilliance: Creating Effortless Abundance while Navigating Business and Motherhood https://amzn.to/418hdwx   2024 Pharmacist Authors Series Part 1 of 3 (June) Episode 282 with Steve Leuck, PharmD - A Pharmacist's Story An Authentic Tale of True Love, Family, Addiction, and the Practice of Pharmacy Part 2 of 3 (July) Episode 288 Helen Sairany, PharmD - The We You Don't See:  Understanding the Long Shadows of Trauma Part 3 of 3 (August) Episode 293 Kim Newlove with Publishing in Doses Co-Founders Janan Sarwar, PharmD and Theary Chhim, PharmD plus audio engineer, Julie Walthers.    2023 Pharmacist Authors Series (Part 1 of 15) June 5, Introduction to the Pharmacist Authors Series (Episode 220) (Part 2 of 15) June 9, The Pharmacist's Voice ® Podcast Episode 221:  Interview with Salam Kabbani, PharmD about her book: COVID Long-Hauler:  My Life Since COVID (Part 3 of 15) June 12, The Pharmacist's Voice ® Podcast Episode 222:  Interview with audio engineer Julie Walthers from Whole Story Studio: https://www.wholestorystudio.com/  (Part 4 of 15) June 16, The Pharmacist's Voice ® Podcast Episode 223 Interview with Erin L. Albert, PharmD on her book The Life Science Lawyer Part 5 of 15) June 19, The Pharmacist's Voice ® Podcast Episode 224 Interview with Sue Ojageer, PharmD on her children's book The Pharma Heroes:  The Power of Precision Medicine (Part 6 of 15) June 23, The Pharmacist's Voice ® Podcast Episode 225: Interview with Tony Guerra, PharmD about his Pharmacist Residency and Career Series (8 books) (Part 7 of 15) June 26, The Pharmacist's Voice ® Podcast Episode 226:  Interview with Christina Fontana, PharmD about her book Moving Beyond the Counter:  Elevating into Heart-Centered Health Care through Entrepreneurship (Part 8 of 15) June 30, The Pharmacist's Voice ® Podcast Episode 227: Interview with Jade L. Ranger, PharmD, about her book Mustard Seed Mentality: Unscripted Pearls of Wisdom from a Wife, Mother, and Entrepreneur (Part 9 of 15) July 7, The Pharmacist's Voice ® Podcast Episode 229: Interview with RDML Pam Schweitzer, PharmD and her daughter Amy Graves about their children's book Alice and Jack Hike the Grand Canyon (Part 10 of 15) July 10, The Pharmacist's Voice ® Podcast Episode 230: Interview with Cory Jenks, PharmD about his book Permission to Care:  Building a Healthcare Culture That Thrives in Chaos (Part 11 of 15) July 14, The Pharmacist's Voice ® Podcast Episode 231: Interview with Donna Bartlett, PharmD about her book MedStrong:  Shed Your Meds for a Better, Healthier You - Aging Well Through Deprescribing  (Part 12 of 15) July 17, The Pharmacist's Voice ® Podcast Episode 232:  Interview with Frieda Wiley, PharmD about her book Telecommuting Psychosis:  From Surviving to Thriving While Working in Your Pajama Pants.  Plus, we touch on her 3 children's books in development. (Part 13 of 15) July 21, The Pharmacist's Voice ® Podcast Episode 233:  Interview with Tim Ulbrich, PharmD about his book Seven Figure Pharmacist:  How to Maximize Your Income, Eliminate Debt, and Create Wealth  (Part 14 of 15) July 24, The Pharmacist's Voice ® Podcast Episode 234:  Interview with LaQuoia Johnson, PharmD about her book How Rxacism Manifests Inside the Small World of Pharmacy (Part 15 of 15) July 28, The Pharmacist's Voice ® Podcast Episode 235:  Pharmacist Authors Series wrap-up (solo show)   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Audiobook Narration Services https://www.kimnewlove.com/narration  ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting Course https://www.kimnewlove.com/podcasting   ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 353 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Steve Moore, PharmD, joined Over the Counter during American Pharmacists Month to discuss community pharmacy innovations, collaborations, and partnerships driving improved patient outcomes.

On today's Good Day Health Show - ON DEMAND…As the popularity of GLP-1 medications for weight loss and diabetes continues to soar, a dangerous new trend is putting patients at risk: compounded and counterfeit versions flooding the market.In this important episode, Doug Stephan is joined by Leigh Verbois, PharmD, JD, FAPhA — board member of the Alliance for Safe Online Pharmacies (ASOP Global) and former FDA official — to uncover the truth about these unapproved and unsafe products.Verbois shares her insider perspective on:• Why compounded GLP-1s can be hazardous to your health• How deceptive online marketing is driving their rapid spread• What patients, providers, and policymakers can do to stay safeWith years of experience leading the FDA's Office of Drug Security, Integrity, and Response, Leigh Verbois brings vital insights on protecting yourself from unverified medications and ensuring your treatments meet federal safety standards.

Did you know that one in five adults skip filling their prescriptions because of cost, and many may be missing out on valuable savings and benefits they didn't even know they had? Tune in for an inspiring discussion with Pharmacist Joshua Fredell, Senior Vice President, Head of PBM and Specialty Product Innovation at CVS Health. Moments with Marianne Radio Show airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.comJoshua Fredell, a pharmacist and Senior Vice President, serves as Head of PBM and Specialty Product Innovation at CVS Health. He oversees ideation, commercialization, and management of the company's pharmacy benefit and specialty management products, including formulary design, network products, specialty cost management, clinical solutions, and medical benefit management. Joshua joined the legacy Caremark Rx corporation in 2003. Currently, Joshua and his team are focused on developing strategies that help create best-in-class savings while supporting clinically robust decision making including targeted formulary approaches for high-cost therapy classes, better control of specialty spend within the medical benefit, and improving the patient/provider experience while lowering overall cost. His team is also focused on continuing to innovate and enhance plan design solutions to help clients stay ahead of emerging market trends in a changing pharmaceutical landscape. Prior to CVS Health, Joshua was part of the pharmacy department of UPMC Health Plan, Joshua holds a Pharm.D. from the University of Pittsburgh.  www.cvshealth.comFor more show information visit: https://www.mariannepestana.com/

Pharmacy driven medication history programs are essential for accurate transitions of care and patient safety, especially in rural and resource-limited settings. Jenny Slavens, from IU Health Arnett shares how her team built a 24/7 regional program that provides medication history support for their community hospital and several critical access facilities. She discusses the shift from a nurse-led to a pharmacy technician-driven model, the operational challenges of scaling services across multiple sites, and the decision to use phone-based interviews to streamline workflows.   Speaker:  Jenny Slavens, PharmD, BCPS  Pharmacy Manager Inpatient Clinical Pharmacy Services  Department of Pharmacy Indiana University Health - West Region   Host:  Jim Lichauer, PharmD, BCPS, FASHP Sr PI Program Director, Pharmacy Performance Improvement Programs Vizient   Show notes: [00:52] – Jenny outlines the structure of the medication history team at IU Health Arnett and how the program operates across facilities [02:10] – Discussion of coverage for critical access hospitals and how the team manages varying hours across sites [02:53] – The evolution from a nurse-led process to a pharmacy-driven model for medication history documentation [04:08] – Why the team shifted from using web-based technology to phone-based medication histories for efficiency and safety [05:20] – How bidirectional communication between pharmacy staff and physicians is maintained through the electronic medical record system [07:03] – Establishing the goal of completing 80% of medication histories within four hours of admission to support timely care decisions [08:55] – How the newly added Tipton facility improved from 10% to 72% completion of medication histories [10:56] – Strategies for balancing staff workload across inpatient, surgical, and emergency admissions [14:22] – Demonstrating the value of the medication history process and creatively using FTE staffing to improve coverage and efficiency   Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com   Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed

PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated Version   

Desiree Chappell and Lieutenant Colonel Daniel P. Raboin, MD, PharmD, U.S. Army anesthesiologist and pharmacist who serves as the Deputy Anesthesiology Consultant to the Army Surgeon General, Lieutenant Colonel Jordan Lane, MD, U.S. Army anesthesiologist at Tripler Army Medical Center in Hawaii and Colonel Michael S. Patzkowski, MD, MHA, Army Anesthesiology Consultant to the Surgeon General. Recorded at Anesthesiology 2025, the annual meeting of the American Society of Anesthesiologists (ASA) conference in San Antonio, we discuss clinical readiness and training programs within Army anesthesiology, cover the importance of maintaining clinical readiness through specialized training, partnership agreements with civilian trauma centers, and how these programs help in preparing anesthesiologists for deployment situations. The discussion also highlights the logistical and administrative challenges of such programs and the solutions implemented to overcome them.

In this episode of Astonishing Healthcare, return guest Libbi Green, PharmD (Manager, Formulary Operations) joins Justin Venneri for a discussion about the 2025 flu season, including the latest vaccine-related updates that employer plan sponsors and plan members need to know. We discuss the effectiveness of last year's flu vaccines, factors influencing the rates, vaccination timing, and how there can be differences in state vs. federal guidelines, among other topics!HighlightsLarger employers may need to tailor flu programs across different states due to varying regulations.Federal agencies - ACIP and the CDC - are recommending the annual flu vaccine but are emphasizing single dose formulations that are free of preservatives.For people who regularly get or would like to get the flu vaccine, the timing is good now, before the end of October. For other vaccines - COVID, etc. - it's important to discuss timing and need with providers to reach a "shared decision."For plan sponsors, working with a PBM partner "to ensure patients have the access that they need and that you're meeting all regulatory compliance" is crucial.Judi®'s flexibility helps allow plan sponsors to react quickly and ensure vaccine-related claims are appropriately processed for their populations.Related ContentWhat employers need to know about federal vaccine policy changes (Mercer)AH072 - The Benefits You Probably Didn't Know You Have, with Marsha PerryAH071 - A Look at What's Really Driving Drug Spend, and How it Impacts Us, with IQVIA's Michael Kleinrock12 New Judi® Features Innovating Pharmacy Benefit AdministrationReference MaterialsInterim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025RSV monoclonal antibody nirsevimab 83% effective in babies, data revealBEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world studyFor more content and information about this episode, including the show notes and transcript, please visit Judi Health - Insights.

Are you measuring your financial success by the wrong metric? In this episode, Tim Ulbrich, PharmD, dives into why income can be misleading and why net worth is the true measure of financial progress. This episode is brought to you by First Horizon. Episode Summary Are you measuring your financial success by income alone? In this episode, Tim Ulbrich shares the wake-up call that changed everything for him: despite earning a six-figure pharmacist salary, his net worth was negative $225,000. Tim dives into why income is a vanity metric and why tracking net worth is the key to true financial progress. He breaks down the difference between income and net worth, why net worth matters more, and four powerful reasons to make it a monthly habit. What you'll learn in this episode: The wake-up moment that shifted Tim's financial mindset Why income alone doesn't reflect real progress How tracking net worth builds momentum, clarity, and motivation Practical tips for measuring what truly matters Mentioned on the Show Your Financial Pharmacist Your Financial Pharmacist on YouTube The Millionaire Next Door by Tom Stanley Rich Dad Poor Dad by Robert Kiyosaki 

Retirement isn't just about the numbers. Tim Ulbrich, PharmD and Tim Baker, CFP® and Registered Life Planner, explore how life planning can help you design a retirement filled with purpose, meaning, and fulfillment, not just financial security. Episode Summary When it comes to preparing for retirement, most conversations focus on the financial side—things like income planning, Social Security timing, withdrawal strategies, and tax-efficient investing. But true retirement readiness goes beyond the numbers. In this episode, Tim Ulbrich, PharmD, is joined by Tim Baker, CFP® and Registered Life Planner, to explore how life planning can help you design a retirement that's rich with meaning, purpose, and fulfillment, not just financial security. As you step away from decades of work—often after raising kids, building a career, and living within a structured routine—you enter a new phase of life where the biggest challenges aren't just financial, they're personal. Who are you now? What does your ideal day look like? How do you make this season of life one that aligns with your values and brings you joy? In this episode, you'll learn: What life planning is and how it complements financial planning How to navigate the personal and emotional transition into retirement Practical ways to align your money with your values and goals How to create a vision for a fulfilling and purpose-driven retirement Whether you're approaching retirement or simply thinking ahead, this conversation will help you see how life planning can make the next chapter not only financially sound but deeply satisfying. Mentioned on the Show Your Financial Pharmacist Your Financial Pharmacist on YouTube YFP 394: Crafting a Rich Life in Retirement: Insights from David Zgarrick, PhD Vanguard Study Advisor's Alpha Changes in US Family Finances from 2019 to 2022: The Federal Reserve Board of Governors

About this episode: Pharmacies do a lot more than dispense medications. In this episode: Christina Madison, known online as the Public Health Pharmacist, explains how pharmacists and pharmacies are able to support critical health needs in communities across the country. Guest: Christina Madison, PharmD, FCCP, is a clinical pharmacist and the founder and CEO of The Public Health Pharmacist, PLLC. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: The Public Health Pharmacist—http://thepublichealthpharmacist.com The Public Health Pharmacist—Instagram Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.